Abstract
Cold agglutinin disease (CAD) is an autoimmune hemolytic anemia (AIHA) generally caused by IgM autoantibodies which exhibit maximal reactivity at 4°C. CAD can be idiopathic or secondary to some diseases and/or conditions. Only a minority of cases of secondary AIHA in non-Hodgkin's lymphoma (NHL) are associated with cold antibodies. Diffuse large B cell lymphoma (DLBCL) is the most common subtype of NHLs with a proportion of nearly 30% of all adult cases. 40% of patients with DLBCL have an extranodal disease or at least disease initially confined to extranodal sites. The most common extranodal site is the gastrointestinal tract. We present a patient with primary gastrointestinal DLBCL who presented with CAD and was treated with a CHOP-Rituximab regimen. Copyright © 2011 S. Karger AG, Basel.
Author supplied keywords
Cite
CITATION STYLE
Eskazan, A. E., Akmurad, H., Ongoren, S., Ozer, O., & Ferhanoglu, B. (2011). Primary gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease. Case Reports in Gastroenterology, 5(2), 262–266. https://doi.org/10.1159/000328445
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.